InvestorsHub Logo
Followers 18
Posts 642
Boards Moderated 0
Alias Born 05/19/2017

Re: None

Wednesday, 08/05/2020 12:36:55 PM

Wednesday, August 05, 2020 12:36:55 PM

Post# of 403036
Brilacidin isn’t just for coronavirus.

With the profile it is showing, it has myriad applications.

Polymedix, Cellceutix/IPIX, the RBLs...have only scratched the surface on this next generation of therapeutics.

Cationic host defence peptides (CHDP), also known as antimicrobial peptides, are naturally occurring peptides that can combat infections through their direct microbicidal properties and/or by influencing the host’s immune responses. The unique ability of CHDP to control infections as well as resolve harmful inflammation has generated interest in harnessing the properties of these peptides to develop new therapies for infectious diseases, chronic inflammatory disorders and wound healing.



http://www.ipharminc.com/new-blog/2020/3/6/review-article-supports-brilacidins-therapeutic-potential-as-a-defensin-mimetic-drug-candidate
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News